UTHR
United Therapeutics Corp

2,416
Mkt Cap
$33.61B
Volume
150,248.00
52W High
$519.99
52W Low
$266.98
PE Ratio
18.28
UTHR Fundamentals
Price
$475.43
Prev Close
$482.39
Open
$480.36
50D MA
$481.79
Beta
0.43
Avg. Volume
454,695.41
EPS (Annual)
$24.64
P/B
3.14
Rev/Employee
$2.2M
News
all
press releases
Nisa Investment Advisors LLC Decreases Stock Position in United Therapeutics Corporation $UTHR
Nisa Investment Advisors LLC decreased its position in United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 38.8% in the 3rd quarter, according to its most recent Form 13F filing with the...
MarketBeat·7h ago
News Placeholder
More News
News Placeholder
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Zacks·1d ago
News Placeholder
UTHR or MDGL: Which Is the Better Value Stock Right Now?
UTHR vs. MDGL: Which Stock Is the Better Value Option?
Zacks·5d ago
News Placeholder
UTHR vs. ZTS: Which Stock Is the Better Value Option?
UTHR vs. ZTS: Which Stock Is the Better Value Option?
Zacks·6d ago
News Placeholder
Insider Selling: United Therapeutics (NASDAQ:UTHR) Director Sells 50 Shares of Stock
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) Director Jan Malcolm sold 50 shares of United Therapeutics stock in a transaction dated Monday, January 5th. The stock was sold at an...
MarketBeat·7d ago
News Placeholder
Christopher Causey Sells 1,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) Director Christopher Causey sold 1,000 shares of the firm's stock in a transaction dated Tuesday, January 6th. The shares were sold at...
MarketBeat·7d ago
News Placeholder
United Therapeutics (NASDAQ:UTHR) Director Christopher Causey Sells 1,000 Shares
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) Director Christopher Causey sold 1,000 shares of the firm's stock in a transaction on Friday, January 2nd. The shares were sold at an...
MarketBeat·8d ago
News Placeholder
Biotech Stocks To Follow Now - January 5th
Amicus Therapeutics, Danaher, argenex, Cidara Therapeutics, United Therapeutics, Vertex Pharmaceuticals, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat's stock...
MarketBeat·8d ago
News Placeholder
United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
United Therapeutics Corporation (Nasdaq: UTHR) announced today that Dr. Martine Rothblatt, Chairperson and Chief Executive Officer, will present a company overview and update on Monday, January 12...
Business Wire·8d ago
News Placeholder
Promising Biotech Stocks To Consider - January 4th
Danaher, Vertex Pharmaceuticals, Cidara Therapeutics, Moderna, and United Therapeutics are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are...
MarketBeat·9d ago
<
1
2
...
>

Latest UTHR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.